N@N

ANAD, MNKD, PBH, BWINB, BCRX, CIR Expected To Be Down After Next Earnings Releases

August 3, 2011 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Thursday, August 4th 2011 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and December earnings reports. ANADIGICS INC (NASDAQ:ANAD), MANNKIND CORP (NASDAQ:MNKD), PRESTIGE BRANDS HOLDINGS INC (NYSE:PBH), BALDWIN & LYONS INC -CL B (NASDAQ:BWINB), BIOCRYST PHARMACEUTICALS INC (NASDAQ:BCRX), CIRCOR INTERNATIONAL INC (NYSE:CIR) are all expected to be Down After their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down After earnings are released Thursday:

     Symbol     Company                             # of Reports            Quarter     Release Time
     ANAD       ANADIGICS INC                       12 Quarter              Q2          Before
     MNKD       MANNKIND CORP                       12 Quarter              Q2          After
     PBH        PRESTIGE BRANDS HOLDINGS INC        6 Quarter               Q1          Before
     BWINB      BALDWIN & LYONS INC -CL B           12 Quarter              Q2          Before
     BCRX       BIOCRYST PHARMACEUTICALS INC        6 Quarter               Q2          Before
     CIR        CIRCOR INTERNATIONAL INC            6 Quarter               Q2          Before

This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

ANADIGICS INC (NASDAQ:ANAD) - ANADIGICS, Inc. provides semiconductor solutions to the broadband wireless and wireline communications markets. Its products include radio frequency (RF) power amplifiers (PAs), tuner integrated circuits, active splitters, line amplifiers, and other components. The companys RF power amplifier products enable mobile handsets, datacards, and other devices to access third generation (3G) wireless networks utilizing international standards, including wideband code division multiple access (WCDMA), high speed packet access (HSPA), code division multiple access (CDMA), and evolution data optimized (EVDO). In addition, the company provides RF power amplifiers for the fourth generation (4G) wireless services, including long term evolution (LTE) and worldwide interoperability for microwave access (WiMAX). ANADIGICSs WiFi products enable connectivity for wireless mobile devices and other computing devices and its cable television (CATV) products enable fixed-point, wireline broadband communications over cable modem and set-top box products, CATV infrastructure, and fiber-to-the-premises (FTTP). The company sells its products through direct sales, as well as through independent manufacturers representatives and distributors. ANADIGICS, Inc. was founded in 1984 and is headquartered in Warren, New Jersey.

MANNKIND CORP (NASDAQ:MNKD) - MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer. Its lead product candidate, AFREZZA, a rapid-acting insulin that has completed Phase III clinical trials for the treatment of diabetes in the United States, Europe, and Japan. The company is also preparing to initiate a Phase II study of MKC1106-MT in patients with advanced melanoma. Its products also include MKC253 (GLP-1), a Phase I clinical trials product for the treatment of type 2 diabetes; and MKC1106-PP, a Phase I clinical trials product for the treatment of diverse tumor types, metastatic diseases, and/or progressive, refractory disease. In addition, the company conducts preclinical studies of drug candidates, MKC204, which may have the potential to treat certain malignancies and inflammatory diseases; MKC180, an obesity compound; and MKC1106-NS, a cancer immunotherapy product. MannKind Corporation was founded in 1991 and is based in Valencia, California.

PRESTIGE BRANDS HOLDINGS INC (NYSE:PBH) - Prestige Brands Holdings, Inc., together with its subsidiaries, engages in marketing, selling, and distributing over-the-counter healthcare, household cleaning, and personal care products in the United States, Canada, and internationally. The companys Over-The-Counter Healthcare segment offers treatments for eye redness relief, eye care, ear wax removal, sore throats and mouth pain, wart removal, bruxism and interdental cleaning, and pediatric care, as well as liquid bandages for protection of small cuts and scrapes, and aerosol spray anesthetic for minor topical pains. It offers these products under the Clear Eyes, Murine, Chloraseptic, Compound W, Wartner, Little Remedies, The Doctors NightGuard, New-Skin, Dermoplast, Percogesic, Freezone, Mosco, Outgro, Sleep-Eze, and Compoz brand names. Its Household Cleaning segment markets household cleaning products, such as abrasive and non-abrasive tub and tile cleaner, scrubbing pads and sponges, and dilutable cleaning products under the Comet, Chore Boy, and Spic and Span brands. The companys Personal Care segment offers nail polish removers, pads, pump action bottles, and manicure correction pens under Cutex brand name. Prestige Brands Holdings distributes its products through various retail channels, including drug, food, dollar, and club stores, as well as supermarkets and mass merchandisers. The company was founded in 1996 and is headquartered in Irvington, New York.

BALDWIN & LYONS INC -CL B (NASDAQ:BWINB) - Baldwin & Lyons, Inc., through its subsidiaries, engages in marketing and underwriting property and casualty insurance products primarily in the United States and Canada. The company provides various fleet transportation insurance products for the motor carrier industry. Its product lines include casualty insurance, such as motor vehicle liability, physical damage, and other liability insurance; workers' compensation insurance; and fidelity and surety bonds. The company also provides specialized accident (medical and indemnity) insurance products for independent contractors; and offers inland marine products primarily consisting of cargo insurance. In addition, Baldwin & Lyons, Inc. offers various additional services, primarily for its insureds, which include risk surveys and analyses, government compliance assistance, and loss control and cost studies, as well as research, development, and consultation in connection with new insurance programs, such as development of computerized systems to assist customers in monitoring their accident data. Further, it provides claims handling services primarily to clients with self-insurance programs. The companys reinsurance business accepts cessions and retrocessions from selected insurance and reinsurance companies, principally reinsuring against catastrophes. Additionally, it markets private passenger automobile liability and physical damage coverage products to individuals through a network of independent agents; and commercial property and business owners liability coverage products. The company was founded in 1930 and is based in Indianapolis, Indiana.

BIOCRYST PHARMACEUTICALS INC (NASDAQ:BCRX) - BioCryst Pharmaceuticals, Inc. designs, optimizes, and develops small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer, and inflammatory diseases. It uses structure-based drug design, which incorporates multiple scientific disciplines, including biology, crystallography, medicinal chemistry, and computer modeling to develop new therapeutic candidates. The company has progressed two compounds into late-stage pivotal clinical trials comprising Peramivir, an anti-viral for influenza; and Forodesine, a purine nucleoside phosphorylase (PNP) inhibitor forcutaneous T-cell lymphoma (CTCL). Peramivir is being developed under a contract from the Biomedical Advanced Research and Development Authority (BARDA) within the United States Department of Health and Human Services (HHS). Forodesine has been granted Orphan Drug status by the FDA for three indications, including T-cell non-Hodgkin's lymphoma, including CTCL; CLL and related leukemias, such as T-cell prolymphocytic leukemia, adult T-cell leukemia, and hairy cell leukemia; and for the treatment of B-ALL. BioCryst Pharmaceuticals is also testing BCX-4208, a second generation PNP inhibitor, which is in a Phase II study for the treatment of gout. The company utilizes crystallography and structure-based drug design to discover additional compounds and to progress others through pre-clinical and early development to address the unmet medical needs of patients and physicians. It has strategic alliances with the U.S. Department of Health and Human Services; Shionogi & Co., Ltd.; Green Cross Corporation; and Mundipharma International Holdings Limited. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is based in Durham, North Carolina.

CIRCOR INTERNATIONAL INC (NYSE:CIR) - CIRCOR International, Inc. engages in the design, manufacture, and marketing of valves and other engineered products and sub-systems. The company operates in three segments: Energy, Aerospace, and Flow Technologies. The Energy Segment offers flanged-end and threaded-end floating and trunnion ball valves, needle valves, check valves, butterfly valves, forged steel ball valves, gate valves, control valves, relief valves, pressure regulators, pipeline measurement, and pipeline closures for use in oil, gas and chemical processing, and industrial applications. This segment provides its products under the brand names of KF, Contromatics, Pibiviesse, Mallard Control, Hydroseal, Sagebrush, and Pipeline Engineering. The Aerospace segment offers precision valves, control valves, relief valves, solenoid valves, couplers, regulators, switches, DC electric motors, and aerospace landing gears for military and commercial aerospace applications. This segment provides its products under the brand names of Aerodyne Controls, Circle Seal Controls, Loud Engineering, Industria, Atkomatic Valve, Survival Engineering, Motor Technology, Bodet Aero, and Atlas Productions. The Flow Technologies segment offers precision valves, compression tube fittings, control valves, relief valves, butterfly valves, couplers, regulators, strainers, and sampling systems for instrumentation, cryogenic, and steam applications. This segment provides its product under the brand names of Cambridge Fluid Systems, Hale Hamilton, Leslie Controls, Nicholson Steam Trap, GO Regulator, Hoke, CIRCORTech, Spence Engineering, CPC-Cryolab, RTK, Rockwood Swendeman, Spence Strainers, Dopak Sampling Systems, Texas Sampling, and Tomco Quick Couplers. The company offers its products through commissioned representatives and direct sales force. It operates in the United States, Canada, Western Europe, and the Peoples Republic of China. The company was founded in 1999 and is based in Burlington, Massachusetts.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641